‘Solve all diseases,’ you say?
At the Google I/O keynote, Demis Hassabis, CEO of Google DeepMind, claimed the company aims to 'solve all diseases' through advanced AI tools. This statement, while ambitious, requires careful interpretation as it may mislead the public about the capabilities of AI in medical research. The reality is that while AI can accelerate drug discovery, significant challenges remain in the field.
- ▪Demis Hassabis announced the goal of solving all diseases using AI at the Google I/O keynote.
- ▪The initiative involves Gemini for Science, a set of experimental AI tools for drug discovery.
- ▪AI has historically played a crucial role in medical research, including the rapid development of COVID-19 vaccines.
Opening excerpt (first ~120 words) tap to expand
ColumnCloseColumnPosts from this topic will be added to your daily email digest and your homepage feed.FollowFollowSee All ColumnAICloseAIPosts from this topic will be added to your daily email digest and your homepage feed.FollowFollowSee All AIScienceCloseSciencePosts from this topic will be added to your daily email digest and your homepage feed.FollowFollowSee All Science‘Solve all diseases,’ you say? Google DeepMind CEO Demis Hassabis made a bold claim at this year’s I/O keynote.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Verge.
Discussion
0 commentsMore from The Verge
